Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...
The gene-editing startup Aera has hired biotech vets Akin Akinc as CEO and John Maraganore as chairman. The two execs previously led the biotech giant Alnylam. They now guide Feng Zhang's latest ...
In this episode of the ChinaPower Podcast, Dr. Feng Zhang joins us to discuss China-North Korea relations in light of the growing Russia-North Korea relationship and deployment of North Korean troops ...
The Boston biotech Aera Therapeutics said on Thursday it had raised $193 million. Feng Zhang, Aera's founder and a CRISPR pioneer, spoke with Insider about his vision for the firm. Aera wants to ...
Aera Therapeutics is launching with $193 million to develop a new nanoparticle technology to deliver genetic medicines to hard-to-reach parts of the body. Months before Feng Zhang met with a trio of ...
Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading ...
The Anna Head Alumnae Hall at UC Berkeley was packed with more than 200 attendees Wednesday evening as Feng Zhang, professor of biomedical engineering at the Massachusetts Institute of Technology and ...
A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results